Screener
Maze Therapeutics MAZE Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's total liabilities?
- Maze Therapeutics (MAZE) reported total liabilities of $78.5M in Q2 2026.
- How has Maze Therapeutics's total liabilities changed year-over-year?
- Maze Therapeutics's total liabilities increased by 90.2% year-over-year, from $41.28M to $78.5M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Maze Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude